aggressive systemic mastocytosis (ASM)
Showing 1 - 25 of 9,756
Advanced Systemic Mastocytosis (AdvSM), SM With an Associated Hematologic Tumor (SM-AHN), Mast Cell Leukemia (MCL) Trial in
Recruiting
- Advanced Systemic Mastocytosis (AdvSM)
- +3 more
- CGT9486 tablets
-
Duarte, California
- +10 more
Jul 8, 2022
Aggressive Systemic Mastocytosis, Systemic Mastocytosis-associated Hematologic Non-mast Cell Disease, Mast Cell Leukemia Trial
Completed
- Aggressive Systemic Mastocytosis
- +3 more
-
Stanford, California
- +10 more
Jan 12, 2023
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematologic Tumor
Active, not recruiting
- Advanced Systemic Mastocytosis
- +3 more
-
Stanford, California
- +31 more
Mar 25, 2022
Advanced Systemic Mastocytosis, Aggressive Systemic Mastocytosis, Systemic Mastocytosis With an Associated Hematological Tumor
Approved for marketing
- Advanced Systemic Mastocytosis
- +3 more
- (no location specified)
Oct 5, 2021
Avapritinib Versus Best Available Therapy in Patients With AdvSM
Completed
- Advanced Systemic Mastocytosis
- +3 more
-
Palo Alto, California
- +5 more
Dec 17, 2021
Advanced Systemic Mastocytosis Trial (BLU-263, Azacitidine)
Not yet recruiting
- Advanced Systemic Mastocytosis
- (no location specified)
Nov 2, 2022
A Registry for Patients With Systemic Mastocytosis in China
Not yet recruiting
- Systemic Mastocytoses
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Aug 24, 2023
Inherited Bone Marrow Failure Syndrome, Familial Platelet Disorder With Predisposition to Myeloid Malignancies Trial run by the
Not yet recruiting
- Inherited Bone Marrow Failure Syndrome
- Familial Platelet Disorder With Predisposition to Myeloid Malignancies
- imatinib
- TruSight Oncology
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 20, 2023
Systemic Mastocytosis, Aggressive (ASM), Leukemia, Mast Cell, Hematological Non-mast Cell Lineage Disease (AHNMD) Trial in
Completed
- Systemic Mastocytosis, Aggressive (ASM)
- +2 more
-
Stanford, California
- +2 more
Sep 19, 2018
Gastrointestinal Stromal Tumors, Advanced Systemic Mastocytosis, Advanced Cancers Trial in Worldwide (DCC-2618)
Active, not recruiting
- Gastrointestinal Stromal Tumors
- +2 more
-
Scottsdale, Arizona
- +25 more
Apr 16, 2021
DALY on a Cohort of Patients With Indolent Systemic Mastocytosis
Recruiting
- Mastocytosis, Indolent Systemic
-
Toulouse, Haute-Garonne, FranceCentre de Référence des Mastocytoses, Service de Dermatologie, H
Jun 19, 2023
Osteoporosis, Systemic Mastocytosis Trial in France (Denosumab, Placebo)
Active, not recruiting
- Osteoporosis
- Systemic Mastocytosis
- Denosumab
- Placebo
-
Besançon, France
- +10 more
Apr 13, 2021
Epilepsy, Epilepsy in Children Trial in Seoul
Recruiting
- Epilepsy
- Epilepsy in Children
-
Seoul, Korea, Republic ofAsan Medical Center
Feb 13, 2023
SSM, Mastocytosis, Indolent, Mastocytosis, Systemic Trial in United States (CGT9486 Tablets, Placebo Tablets)
Recruiting
- SSM
- +3 more
- CGT9486 Tablets
- Placebo Tablets
-
Clearwater, Florida
- +5 more
Apr 14, 2022
Quality of Life and Disease-related Symptoms in Individuals With
Not yet recruiting
- Mastocytosis, Systemic
- No intervention
-
Stockholm, Sweden
- +1 more
Sep 26, 2023
Intervention Engagement and Retention Trial in East Saint Louis (Community Wise)
Recruiting
- Intervention Engagement and Retention
- Community Wise
-
East Saint Louis, IllinoisComprehensive Behavioral Health Center
Jun 28, 2023
Systemic Mastocytosis With AHNMD, Acute Myeloid Leukemia With T(8;21)(Q22;Q22) Trial in Suzhou
Not yet recruiting
- Systemic Mastocytosis With AHNMD
- Acute Myeloid Leukemia With T(8;21)(Q22;Q22)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University, Jiangsu Ins
Aug 16, 2022
Mast Cell Activation Disease, Mast Cell Activation Syndrome, Mast Cell Disease Trial in Poitiers (Ophthalmological examination)
Recruiting
- Mast Cell Activation Disease
- +3 more
- Ophthalmological examination
-
Poitiers, Nouvelle Aquitaine, FranceMasson Regnault
Apr 12, 2022
Study of Mast Cell Precursors
Completed
- Mastocytosis
- Healthy Volunteer
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 4, 2022
Aggressive Systemic Mastocytosis, Mast Cell Leukemia, Systemic Mastocytosis Trial in Stanford, Houston (Brentuximab vedotin)
Completed
- Aggressive Systemic Mastocytosis
- +2 more
- Brentuximab vedotin
-
Stanford, California
- +1 more
Jan 9, 2019
Epilepsy Trial in Heemstede, Rotterdam (Eyes-closed rest-EEG registration, Transcranial Magnetic Stimulation during EEG and EMG
Recruiting
- Epilepsy
- Eyes-closed rest-EEG registration
- +2 more
-
Heemstede, Noord-Holland, Netherlands
- +1 more
Sep 19, 2022
Mastocytosis Trial in Toulouse (Hydroxychloroquine)
Not yet recruiting
- Mastocytosis
-
Toulouse, FranceLarrey Hospital - Toulouse University Hospital
Oct 6, 2021
Mastocytosis Trial in Cambridge
Completed
- Mastocytosis
-
Cambridge, MassachusettsRegistry participation is worldwide and not limited to this faci
Feb 3, 2021
Serum Basal Tryptase Levels in Healthy Children
Completed
- Basal Tryptasemia
- Tryptase dosage
-
Paris, FranceHôpital Necker-Enfants Malades
Dec 8, 2022